An interventional study of Immediate Implant Placement with Medpark S1 xenograft and Immediate Implant Placement with bio-Oss xenograft in Alveolar Bone Loss, Tooth Extraction Status Nos and Immediate Implant Placement, sponsored by Basma Gamal Mohamed Ahmed. Recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2026-03-06.
Sponsored by Basma Gamal Mohamed Ahmed · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 75 studies in Alveolar Bone Loss with a site in Egypt — 22 open to participants now, 27 under way, none of them phase 3. Alveolar Bone Loss · Egypt.
Among the 75 studies in Alveolar Bone Loss with a site in Egypt, this one is the 17th largest by planned enrollment of the 74 interventional ones that give a count, is one of 14 that started in 2025, is one of 68 with no phase, reaches primary completion later than 12 of the 26 other live ones, and was the 59th registered.
320 studies on the registry are indexed under Alveolar Bone Loss; 79 are open to participants now.
Browse Alveolar Bone Loss studies →22 of the 75 studies in Alveolar Bone Loss with a site in Egypt are open now. Recruiting first, the newest first:
Horus University · Sites in Egypt
Ages 25–35 · Healthy volunteers
Beni-Suef University · Sites in Egypt
Ages 20–75 · Healthy volunteers
Al Salam University · Sites in Egypt
Ages 20–45 · Healthy volunteers
Future University in Egypt · Sites in Egypt
Ages 20–50
British University In Egypt · Sites in Egypt
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 47 Alveolar Bone Loss studies recruiting now, 19 (40%) set no upper age limit and 22 (47%) stop at 75 or younger; 4 take children under 18; 24 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
75 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 2 · Phase 3 1 · Phase 4 2
First in 2018; this study’s year is marked. 14 started in 2025.
This study's planned enrollment of 26 is close to the median of 25 across 271 interventional studies indexed under Alveolar Bone Loss.
Median enrollment 20 across the 74 interventional studies, 23 across the 1 observational. Of the 37 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 75 has an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Basma Gamal Mohamed Ahmed as lead sponsor.
Basma Gamal Mohamed Ahmed has 1 study filed under Alveolar Bone Loss — fewer than ten, so there is no comparison to draw.
6 of the studies in Alveolar Bone Loss with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07475507Cairo UniversityEffect of PEEK and Titanium Framework Reinforcement on Marginal Bone Loss Around Implants Supporting a Fixed All-on-four Prosthesis in Completely Edentulous Mandibles | 2026-12 |
| NCT07701473Cairo UniversityNovel Synthetic Membrane for Horizontal Bone Augmentation: A Case Series | 2027-03-01 |
| NCT06313229Kafrelsheikh UniversitySimultaneous Implant Placement With Vertical and Horizontal Bone Augmentation | 2027-04-30 |
| NCT07841158Mohammed Mahmoud AbedHistological and Histomorphometric Assessment With Inflammatory Profile Analysis of Bone Tissue After Horizontal Ridge Augmentation Using Customized Porous Zirconia Shell | 2027-05-01 |
| NCT07869030Future University in EgyptMelatonin Effect on Immediate Dental Implants in the Posterior Mandible | 2027-06 |
Add all 6 to your calendar (.ics) → With an account.
Among the 75 studies in Alveolar Bone Loss with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized clinical trial aims to evaluate labial bone plate changes following immediate implant placement in Type II extraction sockets using two different xenograft materials and de-epithelialized free gingival graft in the esthetic zone . Patients requiring extraction and immediate implant placement will be randomly allocated into two groups according to the xenograft material used for defect grafting. Clinical and radiographic outcomes will be assessed to determine dimensional bone changes and implant success
Immediate implant placement in the esthetic zone has become a predictable treatment modality aiming to reduce treatment time while preserving alveolar bone and soft tissue architecture. However, dimensional alterations of the labial bone plate remain a clinical concern, particularly in Type II extraction sockets.
The present randomized controlled clinical trial will compare the effect of two different xenograft materials and de-epithelialized free gingival graft used for defect grafting during immediate implant placement. Eligible patients indicated for tooth extraction and immediate implant placement will be randomly assigned into two parallel groups based on the grafting material used.
Clinical evaluation and standardized radiographic assessment using CBCT will be performed to measure labial plate thickness changes, peri-implant bone stability, and implant success outcomes over a defined follow-up period. The findings of this study aim to provide clinical evidence regarding the most effective xenograft material for preserving peri-implant hard tissue contours in the esthetic zone
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients undergoing immediate implant placement in Type II extraction sockets with defect grafting using Medpark S1 xenograft .
Procedure: Immediate Implant Placement with Medpark S1 xenograft
Patients undergoing immediate implant placement in Type II extraction sockets with defect grafting using bio-Oss xenograft.
Procedure: Immediate Implant Placement with bio-Oss xenograft
Immediate implant placement in Type II extraction sockets, with gap grafting using Medpark S1 xenograft .
Immediate implant placement in Type II extraction sockets, with gap grafting using bio-Oss xenograft
Labial Bone Plate Thickness Change
Dimensional changes of the labial alveolar bone plate will be measured using standardized CBCT images to assess the effectiveness of the two xenograft materials in preserving bone contour
Time frame: 6 months post-implant placement
Peri-implant mucosal level (PML)
Intraoral scanning will be performed preoperative, immediate postoperative (baseline) and six months postoperatively. The 3D software will be used to align the baseline and six month models using the best-fit algorithm of the software to perfect the superimposition process. The superimposed models will be assessed using specific software, where the measurements will be performed to compare soft tissue outcomes between the two xenograft materials
Time frame: 6 months post-implant placement
Clinical assessment of Pink Esthetic score
Seven variables will be scored: mesial papilla, distal papilla, to curvature of the facial mucosa, level of the facial mucosa and soft tissue color, and texture of facial gingiva at the implant site. A score of 0, 1, or 2 will be given to each parameter obtain a final score of 14 minimum score 0,maximum score 14 higher score means better
Time frame: 6 months post-implant placement
Plan to share: No — This study is a randomized clinical trial designed to evaluate labial bone plate preservation following immediate implant placement in Type II extraction sockets using two different xenograft materials in the esthetic zone. Eligible participants will be randomly assigned to one of two parallel groups based on the xenograft material used for gap grafting. Clinical and radiographic assessments will be conducted to monitor dimensional changes of the labial bone plate, peri-implant tissue health, and implant success over a six-month follow-up period. All procedures will be performed under standard clinical protocols at the Faculty of Dentistry, Alexandria University
No publications or documents are linked to this record.
Started Sep 2025 (actual). Primary completion is estimated for May 2026, 8 months after the start.
Of 169 non-industry interventional studies with no phase under Alveolar Bone Loss, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's planned 8 months is below that.
Counting every sponsor, half of 169 studies reached it within 18 months; a quarter within 11 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.